Home
Conditions
Squamous Cell Carcinoma of Head and Neck

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

NCT00004070

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer

NCT00840814

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +14 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

NCT01256385

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Northwestern University Chicago, Illinois, United States

View all 24 locations

View Trial Details

Completed

DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx

NCT00897988

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

NCT00671437

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: University of Louisville Louisville, Kentucky, United States

Washington University St Louis, Missouri, United States

View Trial Details

Completed

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

NCT00899769

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

NCT00482872

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00095628

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time

NCT01342978

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +13 more
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Mt Sinai School of Medicine New York, United States

Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

NCT00513383

Conditions: Carcinoma, Carcinoma, Adenosquamous, Carcinoma, Squamous Cell, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck trial results

Related conditions